Back

Nxera Pharma settles UK patent infringement case with OMass Therapeutics

Verifying
  • Nxera Pharma UK settled patent infringement proceedings with OMass Therapeutics.
  • The settlement concerns patents EP 3 408 286 B1 and GB 2 558 968.
  • Nxera brought the case before England and Wales’ High Court Patents Court.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.